InvestorsHub Logo

lasers

05/17/16 5:20 PM

#200583 RE: WeeZuhl #200580

WeeZuhl thxs for the input. Very impressive numbers.

no2koolaid

05/17/16 5:44 PM

#200586 RE: WeeZuhl #200580

I expect that the content of this post will be that which the SFP in business development of the potential acquirers of Elite will be discussing and analyzing. All the noise about p/s fails to understand the dramatic impact the fundamentals have on the decisions that will drive this company forward and toward their acquisition. Let's be clear, the SFP in big pharma will consider the market size and growth, both in the US and worldwide, based on demographic changes, as well as improved healthcare offering medical and dental surgeries that improve life while necessitating IR meds to aid in pain management. In short, Elite is one of the companies they have on their short list, merely waiting for proof of concept...because the SFP get paid big bucks to find these little nuggets that cost little in comparison to the incremental financial benefit their company will derive due to synergies and the application of an existing value chain.

BioMania

05/17/16 6:07 PM

#200588 RE: WeeZuhl #200580

Thank you so much for the valuable explanation.

Understand that i am in no way a basher, i own 25k shares $ELTP.

But i cannot get over this question i keep asking myself.

How is a pill classified as an ADF when it can be abused by taking multiple pills at one time to achieve the high?

I know it can't be altered to snort, inject, etc, etc etc.

But wont an abuser just say "ok, i wont activate the antagonist, i will just eat more pills and get high that way"?

Any clarification would be appreciated.

Dr PeteRose MLB

05/17/16 6:45 PM

#200590 RE: WeeZuhl #200580

My pain management Dr will no longer write for OxyContin or Embeda. I have been with him since my industrial injury 8 years ago. If it weren't for his compassion and understanding of who I am and the scope of my Job I would have been disabled and put away. I retired a little over 2 years who and thanks to him I still put in the hours at the farm but with a lot of assistance. I'm more of the "herbalist" and keeper of the greenhouse.
His practice has around 6 other Drs which includes orthopedic surgeon and neurologist all of them associated with The Wexner Medical Center at The Ohio State University. We have talked about ADT opioids and the place in the pain management patient. Like I said he nor the other Drs write for OC and defiantly not Embeda for a couple of reasons. OxyContin is defeated with as little effort as opening a can of cola, and for those that don't want to wait a few hours to cultivate the oxycodone a simple search on Google will give them step by step instructions. Embeda, well it speaks for itself. I asked him about the breakthrough pain meds he said hopefully patients are being honest and he hopes that at least 60%-65%'are using their meds the way they are prescribed. He said it doesn't take long to weed out some of the patients through behavior such as making excuses of running out of meds between appointment and piss test with no opioids present and calling a patient in for a pill count
While he acknowledged some getting through, it will make Drs a little more comfortable knowing that their patients aren't snorting or banging their meds. I have talked to him about SequestOx and he has shares in the .22 range. He also said one of the other Drs in the practice has also bought shares.
What immediate release opioid do you think those 2 Drs are going to write and more likely than not all of the Drs in that practice will be writing SequestOx.
Good Luck to my fellow LONGS.
My one and only post for the day.